|
- (January 2013) FDA approves Botox®(onabotulinumtoxinA) injection for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency, in adults who have an inadequate response to or are intolerant of an anticholinergic medication
- (September 2013) FDA Approves Botox® Cosmetic (onabotulinumtoxinA) for the temporary improvement of moderate to severe lateral canthal lines (crow's feet lines) in adults.
|
